These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9399622)

  • 1. Prolonged hypoglycemic crisis associated with glyburide.
    Sills MN; Ogu CC; Maxa J
    Pharmacotherapy; 1997; 17(6):1338-40. PubMed ID: 9399622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older.
    Greco D; Pisciotta M; Gambina F; Maggio F
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):215-9. PubMed ID: 20072965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
    LeBlanc M; Bélanger C; Cossette P
    Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.
    Yogev Y; Ben-Haroush A; Chen R; Rosenn B; Hod M; Langer O
    Obstet Gynecol; 2004 Jul; 104(1):88-93. PubMed ID: 15229005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Khamaisi M; Leitersdorf E
    Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory hypoglycemia from ciprofloxacin and glyburide interaction.
    Lin G; Hays DP; Spillane L
    J Toxicol Clin Toxicol; 2004; 42(3):295-7. PubMed ID: 15362597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
    Jain R; Osei K; Kupfer S; Perez AT; Zhang J
    Pharmacotherapy; 2006 Oct; 26(10):1388-95. PubMed ID: 16999648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
    Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
    Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide.
    Skoff RA; Waterbury NV; Shaw RF; Egge JA; Cantrell M
    J Manag Care Pharm; 2011 Nov; 17(9):664-71. PubMed ID: 22050391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypoglycemia in diabetic children].
    Tupola S; Rajantie J
    Duodecim; 2000; 116(2):125-31. PubMed ID: 11764469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hardly any hypoglycemias, constant weight--and still cost effective].
    MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 13. Perinatal outcomes and the use of oral hypoglycemic agents.
    Bertini AM; Silva JC; Taborda W; Becker F; Lemos Bebber FR; Zucco Viesi JM; Aquim G; Engel Ribeiro T
    J Perinat Med; 2005; 33(6):519-23. PubMed ID: 16318615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
    Barkin JA; Block HM; Mendez PE
    Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
    [No Abstract]   [Full Text] [Related]  

  • 15. [On 4 cases of severe hypoglycemia (one of which with fatal evolution) after treatment with glibenclamide].
    Codaccioni JL; Rubin P; Mattei A; Vague P
    Diabete; 1971; 19(1):37-41. PubMed ID: 4999032
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
    Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
    J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
    De Vigan C; Delporte MP; Thomas M; Perrault M
    Nouv Presse Med; 1976 Apr; 5(14):906-10. PubMed ID: 818620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
    Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
    Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
    Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
    Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
    Brogard JM; Kuntzmann F; Touitou D; Dorner M
    Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.